Shockwave Medical, Inc.
SWAV
$329.00
$1.480.45%
| Weiss Ratings | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | A- | |||
| Rating Factors | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.72 | |||
| Price History | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.31% | |||
| 30-Day Total Return | 28.10% | |||
| 60-Day Total Return | 46.18% | |||
| 90-Day Total Return | 86.38% | |||
| Year to Date Total Return | 67.66% | |||
| 1-Year Total Return | 22.94% | |||
| 2-Year Total Return | 66.25% | |||
| 3-Year Total Return | 132.45% | |||
| 5-Year Total Return | 983.47% | |||
| 52-Week High % Change | -1.23% | |||
| 52-Week Low % Change | 108.60% | |||
| Price | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $331.58 | |||
| 52-Week Low Price | $157.00 | |||
| 52-Week Low Price (Date) | Nov 10, 2023 | |||
| 52-Week High Price (Date) | Mar 28, 2024 | |||
| Valuation | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 12.28B | |||
| Enterprise Value | 12.06B | |||
| Price/Earnings (TTM) | 84.78 | |||
| Earnings Per Share (TTM) | 3.86 | |||
| Earnings Per Share Growth | -32.14% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 17.11 | |||
| Price/Book (Q) | 18.12 | |||
| Enterprise Value/Revenue (TTM) | 16.52 | |||
| Price | $326.34 | |||
| Enterprise Value/EBITDA (TTM) | 70.36 | |||
| Enterprise Value/EBIT | 74.89 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 38.16M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510 279 4262 | |||
| Address | 5403 Betsy Ross Drive Santa Clara, CA 95054 | |||
| Website | shockwavemedical.com | |||
| Country | United States | |||
| Year Founded | 2009 | |||
| Profitability | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 22.06% | |||
| Profit Margin | 20.16% | |||
| Management Effectiveness | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 9.10% | |||
| Return on Equity | 24.96% | |||
| Income Statement | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 730.23M | |||
| Total Revenue (TTM) | 730.23M | |||
| Revenue Per Share | $19.14 | |||
| Gross Profit (TTM) | 634.84M | |||
| EBITDA (TTM) | 171.45M | |||
| EBIT (TTM) | 161.09M | |||
| Net Income (TTM) | 147.28M | |||
| Net Income Avl. to Common (TTM) | 147.28M | |||
| Total Revenue Growth (Q YOY) | 40.93% | |||
| Earnings Growth (Q YOY) | -68.56% | |||
| EPS Diluted (TTM) | 3.86 | |||
| EPS Diluted Growth (Q YOY) | -68.86% | |||
| Balance Sheet | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 990.55M | |||
| Cash Per Share (Q) | $25.96 | |||
| Total Current Assets (Q) | 1.23B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 668.68M | |||
| Current Ratio (Q) | 11.758 | |||
| Book Value Per Share (Q) | $18.08 | |||
| Total Assets (Q) | 1.57B | |||
| Total Current Liabilities (Q) | 104.21M | |||
| Total Debt (Q) | 770.61M | |||
| Total Liabilities (Q) | 897.89M | |||
| Total Common Equity (Q) | 668.68M | |||
| Cash Flow | SWAV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -625.73M | |||
| Cash from Financing (TTM) | 600.40M | |||
| Net Change in Cash (TTM) | 171.52M | |||
| Levered Free Cash Flow (TTM) | 109.40M | |||
| Cash from Operations (TTM) | 196.05M | |||
